![Paolo Ghia on CLL/SLL and Ibrutinib Plus Venetoclax A Primary Analysis of the CAPTIVATE Trial - The ASCO Post Paolo Ghia on CLL/SLL and Ibrutinib Plus Venetoclax A Primary Analysis of the CAPTIVATE Trial - The ASCO Post](https://cf-images.us-east-1.prod.boltdns.net/v1/jit/5813221795001/a3af0255-561c-4420-905b-142ba6f65034/main/1280x720/2m45s333ms/match/image.jpg)
Paolo Ghia on CLL/SLL and Ibrutinib Plus Venetoclax A Primary Analysis of the CAPTIVATE Trial - The ASCO Post
![Paolo Ghia on CLL/SLL and Ibrutinib Plus Venetoclax A Primary Analysis of the CAPTIVATE Trial - The ASCO Post Paolo Ghia on CLL/SLL and Ibrutinib Plus Venetoclax A Primary Analysis of the CAPTIVATE Trial - The ASCO Post](https://cf-images.us-east-1.prod.boltdns.net/v1/static/5813221795001/c43f3044-2d24-42c6-a41d-8a50185c1b0c/75869329-b183-4eb4-b86e-1b6ad98a39cf/1280x720/match/image.jpg)
Paolo Ghia on CLL/SLL and Ibrutinib Plus Venetoclax A Primary Analysis of the CAPTIVATE Trial - The ASCO Post
![Paolo Ghia on CLL/SLL and Ibrutinib Plus Venetoclax A Primary Analysis of the CAPTIVATE Trial - The ASCO Post Paolo Ghia on CLL/SLL and Ibrutinib Plus Venetoclax A Primary Analysis of the CAPTIVATE Trial - The ASCO Post](https://cf-images.us-east-1.prod.boltdns.net/v1/static/5813221795001/9340cf3a-cf3e-4d93-acdc-8d65f3341676/94aa38d4-848d-47c1-b907-cdd7798942ff/1280x720/match/image.jpg)
Paolo Ghia on CLL/SLL and Ibrutinib Plus Venetoclax A Primary Analysis of the CAPTIVATE Trial - The ASCO Post
![ASH 2020: Dr. Paolo Ghia on the Benefits of Individualized Treatment Plans for Chronic Lymphocytic Leukemia (CLL) - CLL Society ASH 2020: Dr. Paolo Ghia on the Benefits of Individualized Treatment Plans for Chronic Lymphocytic Leukemia (CLL) - CLL Society](https://i.ytimg.com/vi/FxOC0Y7SnyQ/mqdefault.jpg)